TARA icon

Protara Therapeutics
TARA

Overview Fund Activity

25 hedge funds and large institutions have $21.9M invested in Protara Therapeutics in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.57%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
1
Increased
6
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$751K
2
BFM
2
Boothbay Fund Management
New York
$196K
3
Deutsche Bank
3
Deutsche Bank
Germany
$89K
4
BlackRock
4
BlackRock
New York
$74K
5
DS
5
DRW Securities
Illinois
$181K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$352K
2
PI
2
Pharmstandard International
Luxembourg
$3.94M
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
VF
4
Virtu Financial
New York
$0
5
ARTA
5
A.R.T. Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– -$45K -452 Closed
VF
27
Virtu Financial
New York
– -$37K -369 Closed
ARTA
28
A.R.T. Advisors
New York
– -$32K -321 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
– -$31K -307 Closed
LWCFA
30
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$16K -158 Closed
Morgan Stanley
31
Morgan Stanley
New York
– -$1K -10 Closed
1
2